Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
12
|
72
|
0.800 |
None |
0.963 |
0 |
9
|
2003 |
2019 |
Osteosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
4
|
20
|
0.740 |
None |
1.000 |
0 |
9
|
2002 |
2019 |
Li-Fraumeni Syndrome 2
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1
|
11
|
0.700 |
None |
1.000 |
0 |
11
|
2001 |
2018 |
Colorectal Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
43
|
100
|
0.700 |
limited |
0.885 |
0 |
1
|
2003 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
15
|
37
|
0.700 |
None |
0.952 |
0 |
6
|
2001 |
2019 |
Malignant tumor of colon
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
15
|
37
|
0.470 |
None |
0.857 |
0 |
2
|
2001 |
2009 |
ovarian neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
39
|
436
|
0.200 |
None |
0.769 |
0 |
2
|
2002 |
2019 |
Malignant neoplasm of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
11
|
20
|
0.200 |
None |
0.769 |
0 |
1
|
2003 |
2019 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
11
|
28
|
0.200 |
None |
1.000 |
0 |
1
|
2000 |
2017 |
Carcinoma, Ovarian Epithelial
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2
|
3
|
0.200 |
None |
0.750 |
0 |
1
|
2003 |
2019 |
Stomach Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
3
|
5
|
0.160 |
None |
0.833 |
0 |
1
|
2000 |
2018 |
melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
25
|
129
|
0.150 |
None |
0.800 |
0 |
1
|
2004 |
2013 |
Thyroid carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
4
|
4
|
0.130 |
None |
1.000 |
0 |
1
|
2015 |
2019 |
Endometrial Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
15
|
28
|
0.130 |
None |
1.000 |
0 |
4
|
2007 |
2011 |
Lymphoma
|
group |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
6
|
10
|
0.130 |
None |
1.000 |
0 |
1
|
2001 |
2015 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
9
|
12
|
0.110 |
None |
< 0.001 |
0 |
1
|
2018 |
2018 |
Adenocarcinoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
9
|
11
|
0.100 |
None |
|
0 |
2
|
|
|
Polyp of large intestine
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5
|
6
|
0.100 |
None |
|
0 |
1
|
|
|
Type 1 Papillary Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2
|
3
|
0.100 |
None |
|
0 |
2
|
|
|
increased risk of pancreatic cancer
|
phenotype |
Neoplasms
|
Finding
|
5
|
6
|
0.100 |
None |
|
0 |
2
|
|
|
PROSTATE CANCER, SOMATIC
|
disease |
|
Neoplastic Process
|
6
|
18
|
0.100 |
None |
|
0 |
2
|
|
|
Thymus Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
PROSTATE CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
4
|
6
|
0.100 |
None |
|
0 |
2
|
|
|
BREAST CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
11
|
24
|
0.100 |
None |
|
0 |
4
|
|
|
B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified
|
disease |
|
Neoplastic Process
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|